Astrotech (NASDAQ: ASTC) completed a successful 1^st Detect demo with DHS and TSA personnel; TRACER 1000 to be demonstrated at their annual meeting of shareholders on Dec. 7th in Austin, TX.

Astrotech (NASDAQ: ASTC) subsidiary 1^st Detect has entered into a Cooperative Research and Development Agreement with the DHS S&T Transportation Security Laboratory.

Astrotech (NASDAQ: ASTC) subsidiary 1^st Detect, in collaboration with The University of Texas Health Science Center, now called UT Health San Antonio, announced positive preliminary results in pre-clinical trials for the BreathDetect 1000 – a rapid bedside breathalyzer for detecting bacterial infections in the respiratory tract, such as hospital-acquired pneumonia (HAP).

1^ST Detect Corporation, a subsidiary of Astrotech Corporation (NASDAQ: ASTC), announced the United States Patent and Trademark Office (USPTO) issued a key patent for increasing the performance of the company’s unique ion trap mass spectrometer used for chemical analysis and detection. 1^ST Detect’s total patent count is now 17 U.S. and 6 international issued, and 7 U.S. and 10 international pending.

1^ST Detect Corporation was awarded three patents by the United States Patent Office (USPTO) enabling the field use of ion trap chemical analyzers in harsh and demanding environments.